New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Obesity is a risk factor for poor remission rates in RA

Obesity is a risk factor for poor remission rates in RA

For patients with long-standing rheumatoid arthritis treated with anti-tumor necrosis factor-α therapies, obesity is related to poor remission rates, according to a study published online June 21 in&n
Arthritis and Rheumatism March 12,2024
Obesity is a risk factor for poor remission rates in RA

Obesity is a risk factor for poor remission rates in RA

For patients with long-standing rheumatoid arthritis treated with anti-tumor necrosis factor-α therapies, obesity is related to poor remission rates, according to a study published online June 21 in&n
Arthritis and Rheumatism March 12,2024
Belimumab deemed safe for long-term lupus treatment

Belimumab deemed safe for long-term lupus treatment

For patients with systemic lupus erythematosus, long-term belimumab therapy combined with standard therapy is well tolerated, according to a study published online June 5 inArthritis & Rheum
Arthritis and Rheumatism March 12,2024
Belimumab deemed safe for long-term lupus treatment

Belimumab deemed safe for long-term lupus treatment

For patients with systemic lupus erythematosus, long-term belimumab therapy combined with standard therapy is well tolerated, according to a study published online June 5 inArthritis & Rheum
Arthritis and Rheumatism March 12,2024
BMI, post-exercise knee laxity change tied to OA progression

BMI, post-exercise knee laxity change tied to OA progression

In patients with osteoarthritis of the knee, changes in knee joint laxity during stair climbing or other repetitive physical activity and baseline body mass index are associated with disease progressi
Arthritis and Rheumatism March 12,2024
BMI, post-exercise knee laxity change tied to OA progression

BMI, post-exercise knee laxity change tied to OA progression

In patients with osteoarthritis of the knee, changes in knee joint laxity during stair climbing or other repetitive physical activity and baseline body mass index are associated with disease progressi
Arthritis and Rheumatism March 12,2024
Leptin may mediate knee-related osteoarthritis

Leptin may mediate knee-related osteoarthritis

(HealthDay)—The inflammatory adipokine leptin may have a mediating effect on the relationship between body weight and knee osteoarthritis (OA) in older adults, according to research published in the J
Arthritis and Rheumatism March 12,2024
Leptin may mediate knee-related osteoarthritis

Leptin may mediate knee-related osteoarthritis

(HealthDay)—The inflammatory adipokine leptin may have a mediating effect on the relationship between body weight and knee osteoarthritis (OA) in older adults, according to research published in the J
Arthritis and Rheumatism March 12,2024
Keep moving to ease pain of knee arthritis, review says

Keep moving to ease pain of knee arthritis, review says

by Kathleen DohenyResearchers found aerobic, water exercise reduced pain, boosted function in patients.(HealthDay)—Adults with painful osteoarthritis of the knee should turn to exercise—aerobic, aquat
Arthritis and Rheumatism March 12,2024
Keep moving to ease pain of knee arthritis, review says

Keep moving to ease pain of knee arthritis, review says

by Kathleen DohenyResearchers found aerobic, water exercise reduced pain, boosted function in patients.(HealthDay)—Adults with painful osteoarthritis of the knee should turn to exercise—aerobic, aquat
Arthritis and Rheumatism March 12,2024
Walking protects against functional limitation in OA

Walking protects against functional limitation in OA

(HealthDay)—For individuals with or at risk of knee osteoarthritis, walking is associated with reduced incidence of functional limitation over two years, according to a study published in the Septembe
Arthritis and Rheumatism March 12,2024
Walking protects against functional limitation in OA

Walking protects against functional limitation in OA

(HealthDay)—For individuals with or at risk of knee osteoarthritis, walking is associated with reduced incidence of functional limitation over two years, according to a study published in the Septembe
Arthritis and Rheumatism March 12,2024
Arthritis treatment linked to liver problems in study

Arthritis treatment linked to liver problems in study

By Randy Dotinga, HealthDay ReporterBut it's unclear why 'medical food' called Limbrel might make patients sick.(HealthDay) -- A "medical food" called Limbrel, which doctors pres
Arthritis and Rheumatism March 12,2024
Arthritis treatment linked to liver problems in study

Arthritis treatment linked to liver problems in study

By Randy Dotinga, HealthDay ReporterBut it's unclear why 'medical food' called Limbrel might make patients sick.(HealthDay) -- A "medical food" called Limbrel, which doctors pres
Arthritis and Rheumatism March 12,2024
Walking speed is a marker for knee osteoarthritis

Walking speed is a marker for knee osteoarthritis

Slower walking speed may be a marker for identifying those at risk for knee osteoarthritis, according to a study published online March 5 inArthritis Care & Research.(HealthDay) -- Slower wa
Arthritis and Rheumatism March 12,2024
Walking speed is a marker for knee osteoarthritis

Walking speed is a marker for knee osteoarthritis

Slower walking speed may be a marker for identifying those at risk for knee osteoarthritis, according to a study published online March 5 inArthritis Care & Research.(HealthDay) -- Slower wa
Arthritis and Rheumatism March 12,2024
Aggressive lowering of BP may up risk of CHD in diabetes

Aggressive lowering of BP may up risk of CHD in diabetes

Aggressive lowering of blood pressure may be associated with increased risk of coronary heart disease in black or white patients with diabetes, according to research published online May 20 inDi
Arthritis and Rheumatism March 12,2024
Aggressive lowering of BP may up risk of CHD in diabetes

Aggressive lowering of BP may up risk of CHD in diabetes

Aggressive lowering of blood pressure may be associated with increased risk of coronary heart disease in black or white patients with diabetes, according to research published online May 20 inDi
Arthritis and Rheumatism March 12,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com